Hepatitis B Topics HBV Treatment
Coverage of the 2016 AASLD Liver Meeting
- Details
- Category: HBV Treatment
- Published on Sunday, 20 November 2016 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of the 2016 American Association for the Study of Liver Diseases (AASLD) Liver Meeting in Boston, November 11-15, 2016.
Conference highlights include direct-acting antiviral therapy for difficult-to-treat people with hepatitis C, novel hepatitis B agents, complications of viral hepatitis, and NAFLD/NASH.
Full coverage listing by topic
11/20/16
AASLD 2016: Tenofovir Alafenamide Approved for Hepatitis B, Works Well with Less Effect on Bones
- Details
- Category: Approved HBV Drugs
- Published on Monday, 14 November 2016 00:00
- Written by Liz Highleyman
Tenofovir alafenamide (TAF), a new lower-dose pro-drug, matches the older tenofovir disoproxil fumarate (TDF) for antiviral activity against hepatitis B virus but causes less bone mineral loss, according to a report at the AASLD Liver Meeting this week in Boston. The U.S. Food and Drug Administration last week approved stand-alone TAF for hepatitis B treatment.
Hepatitis B Testing Should Be Done Before and During Hepatitis C Treatment
- Details
- Category: HBV Treatment Guidelines
- Published on Thursday, 29 September 2016 00:00
- Written by Liz HIghleyman
People considering treatment for hepatitis C should first be tested for hepatitis B virus (HBV) and monitored throughout therapy, as successful elimination of hepatitis C virus (HCV) can reactivate HBV and potentially worsen liver disease, according to recent updates to American and European hepatitis C treatment guidelines.
Resources for People with HIV and Hepatitis in Disaster Areas
- Details
- Category: HIV Treatment
- Published on Wednesday, 05 October 2016 00:00
- Written by HIVandHepatitis.com
During and after disasters such as Hurricane Matthew, people with medical conditions including HIV and viral hepatitis will be among those displaced and requiring emergency care. Government agencies offer resources for people with these and other chronic conditions, healthcare providers, and others who provide emergency and disaster-related services.
EASL 2016: Hepatitis B Treatment Linked to Colorectal and Cervical Cancer
- Details
- Category: HBV Treatment
- Published on Friday, 03 June 2016 00:00
- Written by Liz Highleyman
People with hepatitis B who were treated with nucleoside/nucleotide antivirals did not have an overall higher rate of malignancies, but did show an increased incidence of colorectal and cervical cancer, underlining the need for regular screening, according to a study presented at the recent EASL International Liver Congress in Barcelona.
More Articles...
- EASL 2016: Antiviral Therapy Linked to Less Liver Cancer and Death in People with Mild Hepatitis B
- EASL 2016: Core Inhibitor NVR 3-778 Plus Pegylated Interferon Inhibits Hepatitis B Activity
- EASL 2016: Tenofovir Alafenamide Works Well Against Hepatitis B with Less Effect on Bones and Kidneys
- AASLD 2015: Hepatitis B Core Inhibitor NVR 3-778 Inhibits Viral Replication
Web Design and Development by